Provided by Tiger Trade Technology Pte. Ltd.

Adlai Nortye Biopharma Co. Ltd.

9.90
-0.0250-0.25%
Volume:232.58K
Turnover:2.30M
Market Cap:365.13M
PE:-8.09
High:9.96
Open:9.92
Low:9.65
Close:9.92
52wk High:12.09
52wk Low:0.8786
Shares:36.90M
Float Shares:19.95M
Volume Ratio:1.26
T/O Rate:1.17%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2226
EPS(LYR):-1.6247
ROE:-138.98%
ROA:-29.81%
PB:46.10
PE(LYR):-6.09

Loading ...

Adlai Nortye Doses First Patient in Phase 1 Trial of Pan-RAS Inhibitor AN9025 for Solid Tumors

Reuters
·
Feb 12

Adlai Nortye Announces First Patient Enrolled in Global Phase 1 Trial of Pan-Ras (on) Inhibitor an9025 for Solid Tumors Harboring Ras Mutations

THOMSON REUTERS
·
Feb 12

Adlai Nortye Secures $140 Million PIPE Financing to Support Oncology Pipeline

TIPRANKS
·
Feb 04

Adlai Nortye kündigt Privatplatzierung über 140 Millionen US-Dollar an

Reuters
·
Feb 04

Adlai Nortye Shares Rise on $140 Million Equity Financing Raise

Dow Jones
·
Feb 03

Adlai Nortye Announces $140.0 Million Private Placement Equity Financing

THOMSON REUTERS
·
Feb 03

Adlai Nortye Ltd (ADR) trading halted, volatility trading pause

TIPRANKS
·
Jan 30

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:45 PM

Reuters
·
Jan 30

Adlai Nortye initiated with a Buy at Lucid Capital

TIPRANKS
·
Jan 29

Asian Equities Traded in the US as American Depositary Receipts Advance in Tuesday Trading

MT Newswires Live
·
Dec 30, 2025

Top Premarket Gainers

MT Newswires Live
·
Dec 29, 2025

Adlai Nortye Ltd. half-year net loss narrows 33.6% to USD 18.3 million

Reuters
·
Dec 29, 2025

Adlai Nortye Signs Exclusive Licensing Deal with ASK Pharm for AN9025 in Greater China

Reuters
·
Dec 29, 2025

Adlai Nortye Enters Exclusive License Agreement With Ask Pharm for Pan-Ras (on) Inhibitor an9025 in Greater China

THOMSON REUTERS
·
Dec 29, 2025

Adlai Nortye Ltd - Eligible for up to RMB 1.6 Bln

THOMSON REUTERS
·
Dec 29, 2025

Adlai Nortye Ltd. Held Extraordinary General Meeting

Reuters
·
Dec 03, 2025

Adlai Nortye to Join Evercore Healthcare Conference

Reuters
·
Nov 21, 2025

Adlai Nortye Ltd. Plans Redomiciliation to Singapore

TIPRANKS
·
Oct 23, 2025

Adlai Nortye Ltd. Announces Date for Extraordinary General Meeting of Shareholders

Reuters
·
Oct 23, 2025

Adlai Nortye Unveils Promising Preclinical Results for AN4035 CEACAM5-Targeting ADC at AACR Conference

Reuters
·
Oct 22, 2025